Giampaolo Tortora Selected Research

Giampaolo Tortora Research Topics

Disease

151	Neoplasms (Cancer) 12/2022 - 02/2002
40	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 10/2012
33	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2002
30	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2002
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 08/2003
24	Neoplasm Metastasis (Metastasis) 04/2022 - 07/2003
19	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 12/2006
19	Carcinoma (Carcinomatosis) 01/2021 - 12/2002
18	Adenocarcinoma 12/2022 - 03/2013
17	Lung Neoplasms (Lung Cancer) 03/2022 - 08/2004
15	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 11/2007
13	Disease Progression 12/2022 - 11/2002
11	Melanoma (Melanoma, Malignant) 03/2022 - 01/2015
9	Colonic Neoplasms (Colon Cancer) 02/2010 - 10/2002
8	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 01/2015
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2003
7	Carcinogenesis 02/2018 - 08/2003
7	Adenocarcinoma of Lung 05/2015 - 02/2005
6	Neutropenia 01/2022 - 08/2014
5	Kidney Neoplasms (Kidney Cancer) 10/2022 - 07/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 01/2015
3	Febrile Neutropenia 01/2022 - 08/2014
3	Cholangiocarcinoma 01/2020 - 12/2013
3	Cardiotoxicity 01/2019 - 08/2014
3	Inflammation (Inflammations) 10/2018 - 01/2014
3	Necrosis 02/2015 - 08/2004

Drug/Important Bio-Agent (IBA)

48	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2002
31	Biomarkers (Surrogate Marker)IBA 04/2022 - 07/2006
24	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2015
23	Tyrosine Kinase InhibitorsIBA 08/2021 - 03/2002
22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 04/2003
18	Gefitinib (Iressa)FDA Link 05/2015 - 03/2002
16	Cetuximab (Erbitux)FDA Link 02/2022 - 12/2003
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
15	Pharmaceutical PreparationsIBA 01/2021 - 04/2003
14	Biological ProductsIBA 04/2022 - 10/2012
14	Monoclonal AntibodiesIBA 02/2022 - 06/2003
13	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 04/2003
13	Hormones (Hormone)IBA 01/2021 - 03/2002
12	Gemcitabine FDA Link 01/2021 - 12/2006
10	vandetanib (ZD6474)IBA 02/2011 - 12/2002
9	Phosphotransferases (Kinase)IBA 04/2022 - 08/2005
9	PlatinumIBA 02/2022 - 01/2016
9	Bevacizumab (Avastin)FDA Link 01/2022 - 07/2007
9	Docetaxel (Taxotere)FDA Link 03/2021 - 12/2004
8	cabozantinibIBA 10/2022 - 01/2016
8	Growth Factor ReceptorsIBA 12/2021 - 06/2002
8	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2017 - 12/2002
7	enzalutamideIBA 01/2018 - 07/2013
7	Epidermal Growth Factor (EGF)IBA 09/2016 - 10/2002
6	NivolumabIBA 10/2022 - 01/2015
6	LigandsIBA 01/2022 - 03/2004
6	Sunitinib (Sutent)FDA Link 11/2021 - 01/2015
6	130-nm albumin-bound paclitaxelIBA 01/2021 - 02/2015
6	Everolimus FDA Link 12/2020 - 01/2015
6	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 04/2003
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 01/2004
6	OligonucleotidesIBA 08/2014 - 04/2003
5	Leucovorin (Folinic Acid)FDA Link 01/2022 - 11/2007
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 11/2007
5	Toll-Like Receptor 9IBA 08/2014 - 01/2006
4	pembrolizumabIBA 06/2021 - 01/2015
4	CrizotinibIBA 11/2020 - 04/2013
4	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2015
4	TensinsIBA 11/2019 - 08/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2019 - 04/2003
4	Trastuzumab (Herceptin)FDA Link 12/2016 - 06/2003
4	EnzymesIBA 04/2016 - 12/2005
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2012 - 03/2004
3	atezolizumabIBA 01/2022 - 01/2015
3	AntibodiesIBA 11/2021 - 01/2015
3	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2018
3	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 10/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2021 - 02/2006
3	palbociclibIBA 01/2021 - 01/2020
3	RamucirumabIBA 01/2020 - 11/2017
3	Panitumumab (Vectibix)FDA Link 11/2019 - 01/2007
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2019 - 01/2015
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2019 - 08/2019
3	abirateroneIBA 10/2018 - 12/2015
3	AndrogensIBA 10/2018 - 11/2002
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 08/2006
3	Glucose (Dextrose)FDA LinkGeneric 09/2016 - 03/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 01/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015 - 03/2002
3	Taxoids (Taxanes)IBA 03/2015 - 04/2003
3	Angiogenesis InhibitorsIBA 01/2015 - 01/2013
3	Anaplastic Lymphoma KinaseIBA 01/2015 - 04/2013

Therapy/Procedure

121	Therapeutics 12/2022 - 02/2002
39	Drug Therapy (Chemotherapy) 02/2022 - 08/2003
26	Immunotherapy 05/2022 - 01/2015
19	Castration 01/2022 - 07/2013
10	Radiotherapy 01/2022 - 10/2002
10	Neoadjuvant Therapy 09/2021 - 08/2014
8	Precision Medicine 04/2021 - 01/2015
5	Combination Drug Therapy (Combination Chemotherapy) 02/2022 - 01/2013
5	Aftercare (After-Treatment) 01/2018 - 02/2003
3	Gastrectomy 03/2021 - 01/2014
3	Nutritional Support (Artificial Feeding) 01/2021 - 01/2018
3	Prostatectomy (Retropubic Prostatectomy) 12/2018 - 11/2002